CBZ trades 11.7% below Wall Street's consensus target of $41.33.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CBZ achieves its forward estimates and maintains a stable P/E multiple of 9.1x. This scenario reflects the blended consensus of 2 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 8, 2026, CBIZ, Inc. (CBZ) has a Wall Street consensus price target of $41.33, based on estimates from 2 covering analysts. With the stock currently trading at $37.00, this represents a potential upside of +11.7%. The company has a market capitalization of $2.03B.
Analyst price targets range from a low of $37.00 to a high of $45.00, representing a 19% spread in expectations. The median target of $42.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 1 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, CBZ trades at a trailing P/E of 20.2x and forward P/E of 9.1x. The forward PEG ratio of 1.70 indicates reasonable valuation for growth. Analysts expect EPS to grow +62.3% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $59.76, with bear and bull scenarios of $37.65 and $78.74 respectively. Model confidence stands at 44/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
ESNTEssent Group Ltd. | $6.0B | $64.60 | $66.25 | +2.6% | Buy | 9.0x | 19 |
KFYKorn Ferry | $3.7B | $72.77 | $80.00 | +9.9% | Buy | 13.7x | 11 |
HURNHuron Consulting Group Inc. | $1.7B | $105.93 | $157.50 | +48.7% | Buy | 12.0x | 9 |
FORRForrester Research, Inc. | $185M | $9.66 | — | — | Hold | 12.6x | 4 |
CASSCass Information Systems, Inc. | $677M | $52.60 | $54.00 | +2.7% | Buy | 17.7x | 2 |
BAHBooz Allen Hamilton Holding Corporation | $7.6B | $63.31 | $89.50 | +41.4% | Buy | 10.4x | 21 |
VRSKVerisk Analytics, Inc. | $25.2B | $192.25 | $226.11 | +17.6% | Hold | 25.1x | 25 |
RHIRobert Half International Inc. | $3.6B | $34.76 | $40.67 | +17.0% | Hold | 26.3x | 25 |
MMSMaximus, Inc. | $3.0B | $56.85 | $110.00 | +93.5% | Buy | 6.7x | 16 |
ASGNASGN Incorporated | $895M | $20.96 | $37.60 | +79.4% | Hold | 5.8x | 13 |
Quick answers to the most common questions about buying CBZ stock.
CBIZ, Inc. (CBZ) has a consensus 12-month price target of $41.33, implying 11.7% upside from $37. The 2 analysts covering CBZ see moderate appreciation potential.
CBZ has a consensus rating of "Buy" based on 2 Wall Street analysts. The rating breakdown is mixed, with 1 Hold ratings making up the largest segment. The consensus 12-month price target of $41.33 implies 11.7% upside from current levels.
With a forward P/E of 9.0952x, CBZ trades at a relatively low valuation. The consensus target of $41.33 implies 11.7% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $45 for CBZ, while the most conservative target is $37. The consensus of $41.33 represents the median expectation. Our quantitative valuation model projects a bull case target of $79 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CBZ is lightly followed, with 2 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CBZ stock forecast based on 2 Wall Street analysts shows a consensus price target of $41.33, with estimates ranging from $37 (bear case) to $45 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $60, with bear/bull scenarios of $38/$79.
Our quantitative valuation model calculates CBZ's fair value at $60 (base case), with a bear case of $38 and bull case of $79. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 44/100.
CBZ trades at a forward P/E ratio of 9.1x based on next-twelve-months earnings estimates compared to a trailing P/E of 20.2x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are optimistic on CBZ, with a "Buy" consensus rating and $41.33 price target (11.7% upside). 1 of 2 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CBZ analyst price targets range from $37 to $45, a 19% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $41.33 consensus represents the middle ground. Our model's $38-$79 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.